Journals / Mucosa / 2020 / Cilt: 3 - Sayı: 4

Skin and mucosa in patients with solid organ transplant: risks and precautions

Solid organ transplantasyonlu hastalarda deri ve mukoza: Riskler ve önlemler

Journal
Mucosa
Pages
83–92
Publication Date
2020-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the following are reviewed along with the current literature; skin and mucosa findings due to immunosuppressive therapies used in solid organ transplant patients, inflammatory, infectious and neoplastic skin diseases which are increased compared to the normal population, and the important points in diagnosis and treatment of these diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In solid organ transplant patients; many skin diseases are more common and more resistant to treatment, because of the multiple medications and immunosuppressive therapies.
📊
Key Findings & Data:In order to increase survival, it is important to evaluate and follow these patients with a multidisciplinary team including the dermatologist.
💡
Conclusion & Impact:In this review, the following are reviewed along with the current literature; skin and mucosa findings due to immunosuppressive therapies used in solid organ transplant patients, inflammatory, infectious and neoplastic skin diseases which are increased compared to the normal population, and the important points in diagnosis and treatment of these diseases.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:organ nakli · immünsupresyon · deri kanserleri

Abstract

In solid organ transplant patients; many skin diseases are more common and more resistant to treatment, because of the multiple medications and immunosuppressive therapies. In order to increase survival, it is important to evaluate and follow these patients with a multidisciplinary team including the dermatologist. In this review, the following are reviewed along with the current literature; skin and mucosa findings due to immunosuppressive therapies used in solid organ transplant patients, inflammatory, infectious and neoplastic skin diseases which are increased compared to the normal population, and the important points in diagnosis and treatment of these diseases.

Özet

Solid organ nakli hastalarının kullandığı çoklu ilaçlar ve immünsupresif tedaviler nedeniyle birçok deri hastalığı bu hasta grubunda daha sık görülmekte ve tedaviye daha dirençli seyretmektedir. Hastaların, sağ kalımlarını arttırmak amacı ile içerisinde dermatoloji uzmanının da bulunduğu bir ekip tarafından multidisipliner olarak değerlendirilmesi ve takip edilmesi önemlidir. Bu derlemede solid organ nakli hastalarında kullanılan immünsupresif tedavilere bağlı görülen deri ve mukoza bulguları, topluma göre sıklığında artış gözlenen enflamatuar, enfeksiyöz ve neoplastik deri hastalıkları ile bu hastalıkların tanı ve tedavisinde dikkat edilmesi gereken noktalar güncel literatür eşliğinde gözden geçirilmiştir.

🔖

Cite This Article

ÖZGEN, Z., OZER, E. C. (2020). Skin and mucosa in patients with solid organ transplant: risks and precautions. Mucosa, Cilt: 3 - Sayı: 4, 83–92. https://ajindex.com/articles/840019

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Alam M, Brown RN, Silber DH, et al. Increased incidence and mortality associated with skin cancers after cardiac transplant. Am J Transplant 2011;11:1488-97.
  2. Metchnikoff C, Mully T, Singer J, et al. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients. J Am Acad Dermatol 2012;67:829-35.
  3. Otley CC, Hirose R, Salasche SJ. Skin cancer as a contraindication to organ transplantation. Am J Transplant 2005;5:2079-84.
  4. Hofbauer GFL, Freiberger SN, Iotzova-Weiss G, Shafaeddin B, Dziunycz PJ. Organ transplantation and skin-principles and concepts. Curr Probl Dermatol 2012;43:1-8.
  5. Ali FR, Samarasinghe V, Russell SA, Lear JT. Increasing capacity for skin surveillance in a transplant review clinic. Transplantation 2014;97:48-50. 6. Ulrich C, Arnold R, Frei U, et al. Skin changes following organ transplantation: an interdisciplinary challenge. Dtsch Arztebl Int 2014;111:188-94.
  6. Lally A, Casabonne D, Newton R, Wojnarowska F. Seborrheic dermatitis among Oxford renal transplant recipients. J Eur Acad Dermatol Venereol 2010;24:561-4.
  7. Mahe E, Morelon E, Lechaton S, et al. Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiologic, histologic, therapeutic, and pathogenic aspects. J Am Acad Dermatol 2006;55:139-42.
  8. Kralund H, Broesby-Olsen S, Bistrup C, et al. Substantial effect of topical cidofovir 1% on recalcitrant warts in a renal-transplanted adolescent: a case report. Transplantation 2011;91:e52-4. Vinzon SE, Braspenning-Wesch I, Muller M, et al. Protective vaccination against papillomavirusinduced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model. PLoS Pathog 2014;10:e1003924. Shiley K, Blumberg E. Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV. Hematol Oncol Clin North Am 2011;25;171-91.
  9. Stephan C, Kurban M, Khalil S, Bitar F, El-Rassi I, Assy J. Viral-associated trichodysplasia spinulosa in a paediatric cardiac transplant recipient. Clinical and Clin Exp Dermatol 2020;45:244-6.
  10. Ozoguz P, Karaca S. Post-transplantation oncological and dermatological problems. Turkiye Klinikleri J Gen Surg-Special Topics 2013;6:142-9.
  11. Hogewoning AA, Goettsch W, van Loveren H, de Fijter JW, Vermeer BJ, Bouwes Bavinck JN. Skin infections in renal transplant recipients. Clin Transplant 2001;15:32-8.
  12. Ponticelli C, Bencini PL. Nonneoplastic mucocutaneous